Home > Boards > US Listed > Biotechs >

Mediwound Ltd (MDWD)

MDWD RSS Feed 		Add MDWD Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017
Search This Board: 
Last Post: 5/6/2021 8:22:26 AM - Followers: 4 - Board type: Free - Posts Today: 1

Description

MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

MediWound Ltd.

42 Hayarkon Street
Yavne 8122745
Israel
972 7 797 14100
http://www.mediwound.com

MDWD
Current Price
Volume:
Bid Ask Day's Range
MDWD Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MDWD News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 05/05/2021 04:15:55 PM
MDWD News: Securities Registration: Employee Benefit Plan (s-8) 05/05/2021 04:06:57 PM
MDWD News: MediWound EPS beats by $0.02, beats on revenue 05/05/2021 07:13:11 AM
MDWD News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 05/05/2021 07:05:42 AM
MDWD News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 04/22/2021 07:40:30 AM
PostSubject
#96   Mediwound (MDWD) Gets a Buy Rating from Oppenheimer midastouch017 05/06/21 08:22:26 AM
#95   Gal Cohen, President & CEO of MediWound Ltd., midastouch017 05/05/21 01:36:37 PM
#94   Perhaps i am mistaken, but i am of the midastouch017 05/05/21 12:03:02 PM
#93   What's very odd, is that BARDA has taken realfast95 05/05/21 11:28:20 AM
#92   the ceo warned that the FDA midastouch017 05/05/21 11:25:24 AM
#91   the ceo warned that the FDA inspection might realfast95 05/05/21 11:09:51 AM
#90   MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates midastouch017 05/05/21 11:01:49 AM
#89   MediWound Ltd. to Host Earnings Call midastouch017 05/05/21 08:15:29 AM
#88   They will have to raise more cash. Maybe realfast95 05/05/21 07:23:56 AM
#87   MediWound Reports First Quarter 2021 Financial Results realfast95 05/05/21 07:12:27 AM
#86   Analysts Estimate MediWound (MDWD) to Report a Decline midastouch017 04/29/21 08:28:12 AM
#85   MediWound to Report First Quarter 2021 Financial Results midastouch017 04/27/21 01:01:25 AM
#84   MediWound Enrolls First Patient in Phase 2 Pharmacology midastouch017 04/22/21 08:12:29 AM
#83   https://www.tipranks.com/stocks/mdwd/forecast midastouch017 04/06/21 12:15:46 PM
#82   What Type Of Shareholders Own The Most Number midastouch017 03/27/21 01:16:52 PM
#81   MediWound Hosting Analyst Day Webinar on EscharEx – midastouch017 03/25/21 03:45:22 AM
#80   Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) midastouch017 03/23/21 02:01:11 AM
#79   MediWound to Participate in Upcoming March Investment Conferences midastouch017 02/26/21 08:21:14 AM
#78   MediWound price target raised to $7 from $5.50 realfast95 02/26/21 07:31:35 AM
#77   MediWound Reports Fourth Quarter and Full-Year 2020 Financial Results midastouch017 02/25/21 08:20:30 AM
#76   MediWound EPS beats by $0.05, beats on revenue realfast95 02/25/21 08:02:49 AM
#75   MediWound Launches Clinical Development Program for Treatment of midastouch017 02/22/21 07:51:07 AM
#74   MediWound to Report Fourth Quarter and Fiscal 2020 midastouch017 02/17/21 03:26:53 AM
#73   MediWound to Participate in the BTIG Virtual MedTech, midastouch017 02/11/21 01:22:51 AM
#72   Coming around sales and income figures, publically trading midastouch017 02/06/21 02:49:46 AM
#71   5.95+0.40 (+7.21%) midastouch017 02/05/21 02:23:58 PM
#70   4.9600+0.2300 (+4.86%) midastouch017 01/28/21 01:33:09 PM
#69   Security MDWD / MediWound Ltd. (M68830104) midastouch017 01/14/21 12:29:12 PM
#68   5.13+0.29 (+5.99%) midastouch017 01/14/21 10:35:45 AM
#67   4.8400+0.4100 (+9.26%) midastouch017 01/14/21 01:13:10 AM
#66   4.6900+0.2600 (+5.87%) midastouch017 01/13/21 09:49:27 AM
#65   4.3598+0.2598 (+6.3366%) midastouch017 01/11/21 11:29:58 AM
#64   MediWound Provides Progress Update on Its EscharEx Clinical midastouch017 01/11/21 08:03:51 AM
#63   Analysts Anticipate MediWound Ltd. (NASDAQ:MDWD) Will Announce Quarterly midastouch017 01/07/21 04:49:50 AM
#62   MediWound to Participate in Upcoming Investor Conferences in January midastouch017 01/05/21 08:05:02 AM
#61   Pipe Line midastouch017 12/23/20 07:57:52 AM
#60   MediWound: A Collectable Investment Worthy Of A Long-Term Hold midastouch017 12/23/20 12:57:04 AM
#59   The biotech company MediWound provided the first midastouch017 12/22/20 03:02:56 PM
#58   4.1800+0.2600 (+6.63%) midastouch017 12/22/20 12:11:46 PM
#57   Successful Completion of In-Vivo Head-to-Head Comparator Study of realfast95 12/21/20 08:21:25 AM
#56   MediWound Continues Global Expansion with Distribution Agreement for realfast95 12/15/20 06:47:01 AM
#55   video from today realfast95 11/18/20 03:15:43 PM
#54   MediWound Q3 EPS $(0.07) Beats $(0.10) Estimate, Sales realfast95 11/10/20 08:04:36 AM
#53   MediWound to Report Third Quarter 2020 Financial Results realfast95 11/02/20 07:03:26 PM
#52   MediWound Completes Enrollment Stage of its NexoBrid Phase realfast95 10/28/20 08:31:14 AM
#51   New burns treatment bears fruit for patients at realfast95 10/22/20 08:23:28 AM
#50   MediWound Studying the Effect of EscharEx on Biofilm Burden realfast95 10/14/20 08:03:52 AM
#49   shhh it's a secret realfast95 10/09/20 09:36:53 AM
#48   Vericel Corporation (NASDAQ: VCEL) today announced that the realfast95 09/16/20 07:38:25 AM
#47   Oppenheimer https://www.tipranks.com/news/article/oppenheimer-3-stocks-that-c realfast95 09/15/20 12:27:20 PM
PostSubject
© 2021 InvestorsHub.com, Inc.
Consent Preferences